Status:

RECRUITING

Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia

Lead Sponsor:

CMH Kharian Medical College

Conditions:

Herpes Zoster (HZ)

Post Herpetic Neuralgia (PHN)

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

Post-herpetic neuralgia (PHN) is the most significant complication of herpes zoster caused by reactivation of latent Varicella-Zoster virus (VZV). PHN is characterized by neuropathic pain lasting beyo...

Eligibility Criteria

Inclusion

  • Diagnosed cases of herpes zoster suffering from postherpetic neuralgia
  • Ages: 18 to 50
  • Both male and female

Exclusion

  • Lack of consent
  • Patient already taking pain killers for post herpetic neuralgia
  • Patients suffering from other systemic illness

Key Trial Info

Start Date :

April 10 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2025

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06969417

Start Date

April 10 2025

End Date

September 30 2025

Last Update

May 14 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CMH Kharian Medical College

Kharan, Punjab Province, Pakistan, 50070

Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia | DecenTrialz